Africa: Protecting access to generic medicines

Recent developments at national and international levels with regards to anti-counterfeiting legislation and actions have raised debate about such laws not undermining access to affordable generic drugs. This policy brief produced by EQUINET, SEATINI and TARSC points to the separate measures and mandates needed to combat firstly fraudulent trade mark and intellectual property (IP) infringement in counterfeit medicines by IP authorities, secondly to ensure that any anti-counterfeit measures protect TRIPS flexibilities, including for access to generic medicines.